{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061558","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2026-09-11T20:13:35+00:00","discovered_at":"2026-09-11T20:15:02.711099+00:00","generated_at":"2026-09-11T20:15:10.637018+00:00","sec_items":["1.02","5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Skye CFO Sharp resigns, CEO Dhillon becomes principal financial officer; regains Nasdaq compliance","bullets":["CFO John P. Sharp resigned Sept. 8, 2026; not due to disagreement with auditors or company.","CEO Punit Dhillon appointed principal financial and accounting officer effective Sept. 8, 2026; compensation unchanged.","Master Services Agreement with Lohman & Associates terminated effective Sept. 8, 2026.","Nasdaq confirmed bid price >=$1.00 for 10 consecutive business days (Aug 24-Sep 4, 2026); compliance regained."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061558","json":"https://secwatch.observer/filing/0001628280-26-061558.json","markdown":"https://secwatch.observer/filing/0001628280-26-061558.md","text":"https://secwatch.observer/filing/0001628280-26-061558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/skye-20260908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T20:15:10.637018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"abf8c6105b","claim":"Punit Dhillon was appointed as Principal Financial and Accounting Officer at Skye Bioscience, Inc..","evidence_excerpt":"In connection with Mr. Sharp’s departure, on September 9, 2026, the Board of Directors of the Company appointed Punit Dhillon, the Company’s President and Chief Executive Officer, as the Company’s principal financial and accounting officer, effective as of September 8, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial and Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"e728ad6603","claim":"John P. Sharp resigned as Chief Financial Officer at Skye Bioscience, Inc..","evidence_excerpt":"On September 8, 2026, John P. Sharp resigned as Chief Financial Officer and principal financial and accounting officer of the Company, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}